OPTN - OptiNose, Inc.

9.6
-0.110   -1.146%

Share volume: 860,961
Last Updated: 05-20-2025
Pharmaceutical Products/Pharmaceutical Preparations: 3.14%

PREVIOUS CLOSE
CHG
CHG%
$9.71
-0.11
-0.01%
This ticker is disabled and data are no longer maintained and up to date.
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 03-31-2024 06-30-2024 09-30-2024 12-31-2024 03-31-2025
Fiscal Quarter Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025
Report Date 05-14-2024 08-08-2024 11-12-2024 03-26-2025 05-14-2025
Total revenue 14.880 M 20.490 M 20.437 M 22.419 M 18.510 M
Cost of revenue 1.231 M 1.981 M 2.065 M 1.954 M 1.750 M
Gross profit 13.649 M 18.509 M 18.372 M 20.465 M 16.760 M
    35.61% -0.74% 11.39% -18.10%  
Operating expenses 21.724 M 25.057 M 20.424 M 20.109 M 24.350 M
Selling general and admin 20.518 M 24.129 M 19.475 M 19.337 M 23.590 M
Research and development 1.206 M 928.000 K 949.000 K 772.000 K 760.000 K
Total expenses 22.955 M 25.057 M 20.424 M 20.109 M 24.350 M
    9.16% -18.49% -1.54% 21.09%  
Operating income -8.075 M -6.548 M -2.052 M 356.000 K -7.590 M
Ebit -8.075 M -3.443 M 4.848 M 356.000 K -18.150 M
Pretax income -14.067 M -7.581 M 467.000 K -12.465 M -22.416 M
    -46.11% -106.16% -2,769.16% 79.83%  
Income tax 0.000 0.000 0.000 0.000 0.000
Net income basic -14.067 M 0.000 0.000 0.000 0.000
    100.00%        
Net income -14.067 M -7.581 M 467.000 K -360.000 K -22.416 M
    46.11% 106.16% -177.09% -6,126.67%